0
4SC is a drug discovery and development company, that uses its cheminformatics-based technology platform for the discovery and development of new clinical drug candidates for the treatment of cancer and inflammatory diseases.
www.4sc.com
A
ACCOVION is a full-service contract research organization offering study planning, study management, clinical monitoring, pharmacovigilance, data management, biostatistics, medical writing, electronic publishing, and document management. We have 200 highly skilled and experienced staff working on regional and global projects, from phase I-IV studies to submission dossiers.
www.accovion.com
The ADT Association of German Technology and Business Incubation Centres coordinates the network of people and initiatives involved in the Innovation Centres and Science and Technology Parks of the Federal Republic of Germany. The prime objective of these Innovation centres is to promote regional economic development through the creation of innovative structures and creation and growth of new technology-oriented enterprises. More than 160 centres in Germany are already full members of ADT and there are additonally approximately 70 Associate members and some European and overseas members. ADT offers its members access to information and exchange of experience, two annual conferences and regular work group meetings. The newsletter, ADT-Info, is published quaterly. ADT also publishes directories of innovation centres and innovative firms. The ADT actively supports projects of the members in setting up innovation centres in other countries.
www.adt-online.de
Affimed is a private biopharmaceutical company specializing in the discovery and development of next generation antibodies for the treatment of cancer and other life threatening diseases with unmet medical need. Affimed has 26 employees and is based in Heidelberg, Germany.
www.affimed.com
AGOWA is an internationally acting genomics company located in Berlin. Founded in 1993, the company offers a broad spectrum of high quality, state-of-the-art genomic and related services as well as products and fully automated solutions for the extraction of nucleic acids.
www.agowa.de
AiCuris (name derived from 'anti-infective cures') is a pharmaceutical company focused on the discovery, research and development of novel antiviral and antibacterial agents for the treatment of severe and potentially life-threatening infectious diseases. AiCuris has its roots in Bayer's long history of successful anti-infective drugs. Spun out in 2006 AiCuris owns a broad portfolio of R&D programms, compounds and intellectual property which have been transferred. It´s experienced management team is headed by Prof. Dr. Helga Rübsamen-Waigmann, Bayer´s former Senior Vice President and Head of Anti-Infective Research, in the position of the CEO. Majority investors are Drs. Strüngmann, the founders and previous owners of Hexal. Bayer keeps a minority share in AiCuris
www.aicuris.com
AMANTEC is a Contract Research Organization (CRO) with offices in Berlin, Frankfurt and Münster. Our long-standing experience and the structure of our company ensure flexibility and effectiveness of the realization of phases I - IV clinical trials. We are able cover all areas of clinical development starting with the trial design to data management including international site monitoring.
www.amantec.de
Founded in 1998, amaxa (www.amaxa.com) develops and markets technologies for the efficient, non-viral transfer of DNA or siRNA especially into primary cells and hard-to-transfect cell lines. The company currently employs 120 people and is based in Cologne, Germany, and Gaithersburg, MD, USA.
www.amaxa.com
AnalytiCon provides services in connection with natural product (NP) drug discovery (e.g. biomaterial procurement, fermentation, extraction, isolation, high throughput structure elucidation and medicinal chemistry). Furthermore, AnalytiCon offers pure natural compound collections and libraries of synthetic, NP-based molecules carrying bio-active structure elements.
www.AC-Discovery.com
Antisense Pharma, a biopharmaceutical company located in Regensburg, Germany, focuses on targeted therapies for malignant tumors. It is dedicated to discovering and developing drugs based on antisense technology for worldwide commercialization.
The agents specifically block the synthesis of key cancer proteins. The lead product AP 12009, a TGF-beta2 inhibitor, is in clinical development for malignant glioma, colorectal carcinoma, pancreatic carcinoma and malignant melanoma.
www.antisense-pharma.com
Apogenix focuses on the preclinical and clinical development of innovative drug candidates which exert their therapeutic effect by modulating the programmed cell death (apoptosis). Indications are acute cerebro- and cardiovascular diseases where apoptosis is abnormally increased, and cancer diseases where apoptosis is abnormally reduced.
www.apogenix.com
Ascenion offers a comprehensive service on all aspects of IP Asset Management in the life-science field. As a partner of several state research institutes, Ascenion manages around 500 patent families, over 100 licence and cooperation agreements, and 11 spin-offs.
www.ascenion.de
ASPIRAS offers pharmaceutical and biotech knowhow based on theory and practice, project management knowhow and financial expertise. The team includes senior professionals with experience in preclinical and clinical development, registration, international marketing and finance.
www.aspiras.de
AVONTEC GmbH is a phase II biopharmaceutical company engaged in the development of a novel class of anti-inflammatory drugs that are based on double-stranded DNA oligonucleotides acting as decoys (decoy ODNs) for transcription factors. AVONTEC’s most advanced clinical development programs focus on the indications asthma (AVT-01) and psoriasis (AVT-02).
www.avontec.de
Axiogenesis AG is a biotechnology company resident in Cologne, Germany, that develops innovative cellular assay systems based on differentiated murine embryonic stem cells and provides these for use primarily in the chemical, pharmaceutical and cosmetic industry. The focus here is firstly the detection of toxic effects and secondly the development of innovative screening systems for the identification of novel therapeutic concepts.
www.axiogenesis.com
B
Baker & McKenzie belongs to the world"s largest law firms. In Germany it has offices in Berlin, Düsseldorf, Frankfurt & Munich. With a team of more than 15 IP attorneys in Germany, we advise numerous multi-national companies and also many start up businesses and research enterprises in the field of life sciences regarding technology licensing.
www.bakernet.com
Situated in the heart of Berlin, with excellent public transport connections and attractive surroundings, berlinbiotechpark currently offers approx. 53,000 m of office, laboratory and production space and a development potential for a further 50,000 m. Due to the media supply, infrastructure and technical services offered, berlinbiotechpark enables companies from all sectors of the Life Science business to combine research, development and production activities in one location and the flexibility to expand.
www.berlinbiotechpark.de
BIOBASE (www.biobase-international.com) develops and distributes molecular biological databases for industrial and academic applications. BIOBASEs product portfolio includes TRANSFAC®, TRANSPATH®, BRENDA® and the Proteome Bioknowledge Library®, internationally acclaimed, manually curated molecular biological databases.
So far, over 70 biotechnological and pharmaceutical companies and over 350 academic institutes are satisfied customers of the company.
www.biobase.de
BioCentiv, a Jena based service company, accommodates and facilitates young businesses active in life sciences. Our BioInstrumentation Centre is state of the art and supports all your office and lab needs from high level research through to early production. We follow through and help you make the best of your module with continuous facility servicing. From funding to project management we offer hands on support to your business. Our local knowledge will accelerate your company into a strong network of partners and potential customers.
www.biocentiv.com
Since 1986 BIOCOM AG, Berlin, is a renowned provider of qualified biotechnology-related information resources. Amongst its most important products are specialized periodicals like Itranskript, LABORWELT, and European Biotechnology News, the BioTechnologie book programme, as well as the new online-platform www.biotechnologie.de.
www.biocom.de
Biofrontera AG, based in Leverkusen, is specialized in the development of pharmaceutical products in the area of dermatology. The company is characterized by a broad, relatively close to the market product portfolio, which is well suited for own distribution in selected European countries.
www.biofrontera.com
BioGeneriX AG is a subsidiary of ratiopharm, an international market leader for generics. Generics are high-quality but low-cost reproductions of patent-free chemical drugs. BioGeneriX was founded in 2000 in order to develop biotechnologically produced drugs, whose active agents are extracted from cell or bacteria cultures, for launch on the international markets upon expiration of a patent.
www.biogenerix.com
BioGenes is an outsourcing partner and service provider for the pharmaceutical and biotechnological industry and research institutes worldwide since 1992. Our certified company (DIN EN ISO 9001:2000) offers immunological and protein biochemical services. BioGenes’ special expertise lies in development and production of monoclonal and polyclonal antibodies as well as immunoassay development, validation and production.
www.biogenes.de
Since 1995 the BioInstruments Jena Association provides support for scientists, the development of concepts, their transfer into marketable products, and the following commercialization. Our cluster is focussed on instruments, methods and technologies for biotechnologists and the pharmaceutical industry. The portfolio comprises high-capacity microscopes, HTS-robots, fluorescent dyes, GMP-production lines for proteins, microarrays and readers.
www.bioinstrumente-jena.de
BioM Biotech Cluster Development GmbH is the central point of contact in the BioTech-Region München, providing consultancy and financial support as well as other services.The main aim of BioM is to further the development of the BioTech-Region München and promote it as one of the leading life science clusters in Europe. As a "one-stop-location" BioM offers business advice, public relations and a network providing important contacts to biotech companies.
www.bio-m.org
www.biotech-bayern.de
Start-up businesses require adequate technical installations and rooms as well as professional support for a successful beginning; the Innovation and Founding Center IGZ in Wuerzburg offers both. The two segments of the IGZ building named BioMed (for life sciences) and ZmK (for communication and IT) are working together synergetically.
www.wuerzburg.de/biomed
The aim of the company is the strengthening of the biotechnological industry in the State of Saxony-Anhalt and the coordination and implementation of the State"s biotechnology strategy. Further, we participate in the "Cluster Biotechnology/Life Sciences Central Germany" with our colleagues from the States of Thuringia and Saxony.
www.biomitteldeutschland.de
The BIO NET LEIPZIG Technologietransfergesellschaft mbH, that was founded with regard to the opening of the Biotech-Center BIO CITY LEIPZIG in 2003 acts as an important contact for consulting and management services in the area of Biotechnology/ Life Science mediating between scientific research and local economy.
The company has focused on three main business areas:
BIO START (founder"s and financial consulting)
BIO COACH (project management and strategic consulting)
BIO TALK (local information and communication platform)
www.bio-city-leipzig.de
-
The BioPark Regensburg GmbH is the management of the biotechnology research cluster known as BioRegio Regensburg in the heart of Bavaria. Located at the northernmost point of the Danube, currently 39 firms with over 1700 employees are active in the field of life sciences. As a result, the BioRegio Regensburg has become the most important region for Biotechnology in Bavaria, second only to Munich.
www.bioregio-regensburg.de
The Biopharm team and competencies
As a consequence of our expertise in research and development and in the analysis of recombinant proteins, we have had very promising results with our human growth and differentiation factor rhGDF-5, which is currently being tested in different clinical trials through our licensees Johnson&Johnson (orthopaedics) and Scil Technologie/Medtronic (maxillofacial). This is reason enough to support our customers in the development of biological therapeutic agents with our know-how and our more than 20 years of experience.We operate internationally and offer our customers the analysis of classical and recombinant active substances and drugs and the implementation or development of various cell culture projects. All work is done GLP/GMP-compliant. We apply the strictest quality criteria to our work, which has been carried out in an established Quality Assurance environment for many years. We offer our customers efficient job processing, professionalism, punctuality and the suitable infrastructure. We guarantee the highest standards, as reliability is what counts.
www.biopharm.de
The association BioRegion Rhein-Neckar-Dreieck e.V. comprises research institutions such as Heidelberg University, EMBL and German Cancer Research Centre, global companies such as Roche Diagnostics, BASF, Abbott and Merck KGaA as well as more than 50 biotech and service companies working together with local authorities, chambers etc. to support further development of life sciences in the Heidelberg region.
www.bioregion-rnd.de
www.bioregio-stern.de
BioRegio STERN Management GmbH promotes biotechnology in the public interest in the Stuttgart and Neckar-Alb regions and the cities of Stuttgart, Tübingen, Esslingen und Reutlingen.
SERVICES: Consultancy,communication,coordination,networking marketing are the company's key tasks, making it the central point of contact for all biotech businesses in the STERN region.
REPRESENTING INTERESTS:
The company represents the economic and scientific interests of new business founders, entrepreneurs and researchers when dealing with the political sector, investors, the media and associations.
BioRN Cluster Management GmbH is a public-private partnership between the Rhine-Neckar BioRegion, the Heidelberg Technology Park, the Rhine-Neckar Chamber of Commerce and the Rhine-Neckar Metropolitan Region. The company is charged with the coordination, integration, development and marketing of the Biotech Cluster Rhine-Neckar (BioRN) - one of the leading life science clusters in Europe.
www.BioRN.org
biosaxony - the coordination agency for biotechnology for the Freestate of Saxony - is the on-stop-shop for all matters regarding biotechnology in Saxony, from information gathering and communications to settlement. biosaxony accesses a trusted regional, national and international network of governmental, industrial and funding/financing partners. biosaxony services companies, investors, scientists and politics. The cluster provides strong expertise in regenerative medicine amd molecular bioengeneering. State of the art infrastructure in an attractive city-setting, an excellent qualified pool of scientists and short decision making processing facilitate a close cooperation between academic institutes and innovative biotech companies
www.biosaxony.com
BIOSCIENCE Valuation BSV GmbH is a management consulting firm that is specialized in the quantitative and qualitative evaluation of R&D projects and portfolios, biotech companies, licensing & partnering agreements and M&A opportunities in order to maximize value. This can be achieved through a comprehensive analysis of a drug"s market potential and R&D risk, leading to optimized development, partnering and marketing strategies.
www.bioscience-valuation.com
BioSpring produces oligonucleotides especially forpharma, diagnostics, chip technologies and molecularbiology. We work with our co-operation partners todevelop therapeutic agents, as well as diagnosticprocedures based on nucleic acids. In addition, withour proprietary PHENOlution process, we also developenyzmes tailored to specific industrial applications.
www.biospring.de
Biotectid is specialized in the development and production of innovative in vivo diagnostics for medical imaging of chronic inflammation diseases. The main indication of which is rheumatoid arthritis (joint rheumatism). The company maintains an in-house GMP-production plant for IMP"s. The lead-product is already in clinical trials.
www.biotectid.de
BioTOP Berlin Brandenburg is the central contact and coordination office for all issues concerning biotechnology in the German capital region. Our special profile as a network node supports you with all questions you may have- quickly and outcome-oriented.
www.biotop.de
Biotype AG is specialised in genotyping and molecular biological analyses in forensic science and human or veterinary medicine. The company develops, validates, produces and distributes molecular genetic test systems for fast and sensitive PCR diagnostic.
www.biotype.de
The non-profit-making BioValley Deutschland e.V. aims for the superior goal to concentrate and develop the trinational, cross-border resources in the field of life sciences and biotechnology. In the context of the BioValley-Initiative, BioValley Deutschland e.V. offers a platform in the first instance for entrepreneurs and founder of a new business.
www.biovalley.de
Bird & Bird is one of the leading international law firms in Europe. As a full service firm, Bird & Bird provides legal advice in all areas of international commercial law with a strong sector focus. A very important area of expertise is Bird & Bird"s Life Science practice.
www.twobirds.com
bitop develops and markets its products on the basis of extremolytes, a group of natural substances, which is responsible for the stress resistance of extremophilic microorganisms. bitop develops its extremolyte-platform for applications in the field of: Consumer Care (Cosmetic/Skin Care), Medical Devices, Pharmaceuticals and Life Science-Products (Biostab Protein Stabilizer).
www.bitop.de
German Patent Attorneys, European Patent Attorneys und European Trade-mark Attorneys
The firm of Bonnekamp & Sparing in Düsseldorf is counsel for all intellectual property matters, particularly for patents, trademarks, design and all matters related thereto in Germany, Europe and worldwide. Among technical emphasis of the firm are life sci-ence and biotechnology. The contact attorney for these technical areas is Dr. Volker Mann. The firm provides legal advice for medium and large companies, as well as for research institutes, start-ups and independent inventors.
www.bonnekamp-sparing.de
BRAIN is a leading provider of novel enzymes, biocatalysts and bioactives for the chemical, pharmaceutical and cosmetic industry. Since 1993 its technologies, proven in various successful partnerships for "white biotech" developments, open up the untapped microbial biodiversity of nature.
www.brain-biotech.de
www.BusinessWire.com oder www.BusinessWire.de
C
Celgene was founded in New Jersey, USA, in 1986. At the moment, more than a thousand employees are working for the company worldwide. The recent foundation of European Headquarters in Neuchatel, Switzerland, shows the commitment of Celgene to develop and market new therapies for unmet medical needs also within the European healthcare system. Affiliates in the most important countries will create hundreds of new jobs in Europe during the next years.
www.celgene.com
cellasys offers system solutions for online analysis of living cells. These include services as research and development, production and maintenance of cell based assays. Furthermore we are consultant for developent of applications, data analysis and data interpretation. The cell based assays monitor different parameters directly at living cells. These parameters are extracellular acidification (ph), cellular respiration (pO2) and morphology (impedance) of the cells. The measurement is label-free, parallel, continous and in real-time. With this cell based assays one can e.g. determine the efficiency of a drug outside of humans (or animals) previous to the start of the therapy. Another possible application is to continuously monitor the vitality of cells in a micro-fermenter
www.cellasys.com
CellGenix is an innovative, market oriented Biotech Company focused on individualized and tailor-made cell and protein therapeutics for cancer treatment and orthopedic surgery. In addition, the company provides high-quality GMP grade reagents and culture medium for ex vivo therapeutic cell processing.
www.cellgenix.com
Cephalon GmbH, based in Martinsried near Munich, is a subsidiary of the US biopharmaceutical company Cephalon Inc. The subsidiary was founded in 1997 to market drugs in Germany, Austria und Switzerland. The company is currently marketing seven products in the indications CNS, Oncology, pain and sleep medicine.
www.cephalon.de
CEVECs business is the development of an innovative platform technology for the production of biopharmaceuticals in human cell lines. Using this proprietary process technology CEVEC has world wide USP for the use of human amnion cell lines (CAP-Cells) as expression system, which provide new opportunities for the production of antibodies, enzymes and growth factors
www.cevec-pharmaceuticals.com
CMS Hasche Sigle is one of the leading German law firms with more than 450 lawyers. It covers the entire area of commercial law and provides legal advice to major German and international companies from a wide spectrum of industry. CMS Hasche Sigle operates at all the major business centres.
www.cms-hs.com
co.don® AG is one of the leading biopharmaceutical companies in the area of Regenerative Medicine/Tissue Engineering. Since 1997, co.don® AG has developed, manufactured and distributed human Tissue engineering therapeutics for the regeneration of articular cartilage, bone and intervertebral discs.
www.codon.de
Commerzbank is the leading bank to German Mittelstand as well as strategic partner to large and capital market-oriented companies, employing 36,448 people and having a balance sheet total of € 626.3 bn. The Corporates and Markets division provides corporate and institutional clients with a broad range of investment banking products. Life Sciences & Chemicals are core sectors of Commerzbank and enjoy highest priority within the entire group.
www.commerzbank.de
Curacyte AG is a research-based biopharmaceutical company initially dedicated to the discovery and development of novel and effective protease inhibitors. Curacyte focuses its R&D activities on cardiovascular and inflammatory diseases. The company’s lead product PHP has successfully completed three Phase II trials in distributive shock and the FDA has accepted the pivotal Phase III protocol.
www.curacyte.com
CureVac GmbH, a fully integrated Tuebingen-based biopharmaceutical Company, has its focus on the development of mRNA based drugs to combat cancer. Maintaining an own GMP production plant, CureVac invented an
improved messenger RNA (RNActiveTM) comprising a prolonged in vivo stability and higher expression levels on an early time point, than related DNA-technologies. With CureVac´s stabilised mRNA a safe access to genetic vaccines is given.
www.curevac.com
Cytonet provides successful solutions to heal life-threatening diseases by using pharmaceuticals based on human cells while using the competence in cell-therapy to extend the world-wide leading position in in vitro and in vivo therapy of heaviest disease of vital parts, especially the liver.
www.cytonet.de